FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

330442009: Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3692825018 Betamethasone sodium phosphate 1 mg/g eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692826017 Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone sodium phosphate 1 mg/g eye ointment Is a Product containing betamethasone in topical dosage form false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment Is a Miscellaneous eye preparations false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Betamethasone sodium phosphate false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment Is a Product containing betamethasone in ophthalmic dosage form false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment Has manufactured dose form Eye ointment true Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment Has concentration strength denominator value un false Inferred relationship Some 1
Betamethasone sodium phosphate 1 mg/g eye ointment This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Betamethasone sodium phosphate 1 mg/g eye ointment Count of base of active ingredient un false Inferred relationship Some
Betamethasone sodium phosphate 1 mg/g eye ointment Has concentration strength numerator value un false Inferred relationship Some 1
Betamethasone sodium phosphate 1 mg/g eye ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Betamethasone sodium phosphate true Inferred relationship Some 1
Betamethasone sodium phosphate 1 mg/g eye ointment This attribute specifies the denominator unit for the concentration strength of a product. g true Inferred relationship Some 1
Betamethasone sodium phosphate 1 mg/g eye ointment This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Betamethasone sodium phosphate true Inferred relationship Some 1
Betamethasone sodium phosphate 1 mg/g eye ointment Is a Betamethasone only product in ocular dose form true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start